Two AstraZeneca drugs get EU backing for treatment of some breast cancers | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

Two AstraZeneca drugs get EU backing for treatment of some breast cancers

/ 04:36 PM June 27, 2022

Two AstraZeneca drugs get EU backing for treatment of some breast cancers

The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021. REUTERS FILE PHOTO

AstraZeneca said on Monday its cancer drugs Lynparza, developed with Merck & Co and Enhertu, developed with Japan’s Daiichi Sankyo, were recommended for the treatment of some high-risk breast cancers in the European Union.

RELATED STORIES

Article continues after this advertisement

FEATURED STORIES

Article continues after this advertisement

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

EDITORS' PICK
sports
opinion
usa
business
entertainment
technology
TAGS: AstraZeneca, Drugs

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.